6 BlackRock BioAge Labs Trades
BlackRock acquired 2.27M BioAge Labs shares worth $38.6M. That's 0.00% of their equity portfolio (2568th largest holding). The first BioAge Labs trade was made in Q4 2024. Since then BlackRock bought shares four more times and sold shares on one occasions. The stake costed the investor $27.5M, netting the investor a gain of 40% so far.
News about BioAge Labs, Inc. and BlackRock
Monroe Capital Supports Superior Waste Industries, LLC's Add-On Acquisitions
CHICAGO--(BUSINESS WIRE)--Monroe Capital LLC (“Monroe”) announced it acted as sole lead arranger and administrative agent on the funding of a senior credit f...
SDS: Geopolitical Uncertainity Driving This Higher (Technical Analysis)
Our Model Portfolio went to cash due to market sell signals, now allocating $50,000 to the inverse ProShares UltraShort S&P500 ETF. Our short-term thesis is ...
Inverse ETFs to Play Now on Middle East Tension & Rising Rates?
Wall Street wavered this week on high inflation data which lowered chances of an imminent Fed rate cut. Plus, geopolitical tension in Middle East has weighed...
Understanding Bull And Bear Market Cycles With Jon Wolfenbarger
Jon Wolfenbarger aims to help individual investors generate double-digit profits and beat the market in both bull and bear markets.